Proteomics Studies on Extracellular Vesicles Derived from Glioblastoma: Where Do We Stand?
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25189778 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Patricia Giuliani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical, Oral and Biotechnological Sciences, 'G. D'Annunzio' University of Chieti-Pescara, Via Vestini 31, 66100 Chieti, Italy. Hauptthemen laut MEDLINE: Glioblastoma, Extracellular Vesicles, Proteomics, Brain Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Like most tumors, glioblastoma multiforme (GBM), the deadliest brain tumor in human adulthood, releases extracellular vesicles (EVs). Their content, reflecting that of the tumor of origin, can be donated to nearby and distant cells which, by acquiring it, become more aggressive. Therefore, the study of EV-transported molecules has become very important. Particular attention has been paid to EV proteins to uncover new GBM biomarkers and potential druggable targets. Proteomic studies have mainly been performed by “bottom-up” mass spectrometry (MS) analysis of EVs isolated by different procedures from conditioned media of cultured GBM cells and biological fluids from GBM patients. Although a great number of dysregulated proteins have been identified, the translation of these findings into clinics remains elusive, probably due to multiple factors, including the lack of standardized procedures for isolation/characterization of EVs and analysis of their proteome. Thus, it is time to change research strategies by adopting, in addition to harmonized EV selection techniques, different MS methods aimed at identifying selected tumoral protein mutations and/or isoforms due to post-translational modifications, which more deeply influence the tumor behavior. Hopefully, these data integrated with those from other “omics” disciplines will lead to the discovery of druggable pathways for novel GBM therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical, Oral and Biotechnological Sciences, 'G. D'Annunzio' University of Chieti-Pescara, Via Vestini 31, 66100 Chieti, Italy.
- Center for Advanced Studies and Technology (CAST), 'G. D'Annunzio' University of Chieti-Pescara, Via L Polacchi 13, 66100 Chieti, Italy.
- Department of Innovative Technologies in Medicine and Dentistry, 'G. D'Annunzio' University of Chieti-Pescara, Via Vestini 31, 66100 Chieti, Italy.
- Stem TeCh Group, Via L Polacchi 13, 66100 Chieti, Italy.
ORCID-Profile: Renata Ciccarelli
Zitieren
APA
Giuliani, P., De Simone, C., Febo, G., Bellasame, A., Tupone, N., Di Virglio, V., di Giuseppe, F., Ciccarelli, R., Di Iorio, P., & Angelucci, S. (2024). Proteomics Studies on Extracellular Vesicles Derived from Glioblastoma: Where Do We Stand?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25189778
Vancouver
Giuliani P, De Simone C, Febo G, Bellasame A, Tupone N, Di Virglio V, et al. Proteomics Studies on Extracellular Vesicles Derived from Glioblastoma: Where Do We Stand?. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25189778
BibTeX
@article{Giuliani2024,
author = {Giuliani, Patricia and De Simone, Chiara and Febo, Giorgia and Bellasame, Alessia and Tupone, Nicola and Di Virglio, Vimal and di Giuseppe, Fabrizio and Ciccarelli, Renata and Di Iorio, Patrizia and Angelucci, Stefania},
title = {Proteomics Studies on Extracellular Vesicles Derived from Glioblastoma: Where Do We Stand?},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25189778}
}
EUVIMED